Skip to main content

Calvin Sandra's Form 4 filing

Travere Therapeutics, Inc. (TVTX) · filed Apr 16, 2026

Accession no.
0001882909-26-000003
Filed
Apr 16, 2026
Trade date
Apr 14, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $902.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Calvin SandraCIK 0001882909Officer (SVP, CHIEF ACCOUNTING OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 14, 2026Common StockMOption exerciseAcquired+2,500$22.40+$56,00051,580Direct
Apr 14, 2026Common StockMOption exerciseAcquired+6,250$8.93+$55,812.557,830Direct
Apr 14, 2026Common StockMOption exerciseAcquired+6,500$20.46+$132,99064,330Direct
Apr 14, 2026Common StockSSaleDisposed−21,977$41.07−$902,595.3942,353Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 14, 2026Common StockMOption exerciseDisposed−2,500$0.00$05,000Direct
Apr 14, 2026Common StockMOption exerciseDisposed−6,250$0.00$012,500Direct
Apr 14, 2026Common StockMOption exerciseDisposed−6,500$0.00$019,500Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)